Log in to save to my catalogue

The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors

The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_330c2dff71754c44b2d110c583e6ecdb

The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors

About this item

Full title

The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2020-12, Vol.14 (1), p.31

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Matrix metalloproteinases (MMPs) have been demonstrated to have both detrimental and protective functions in inflammatory diseases. Several MMP inhibitors, with the exception of Periostat
, have failed in Phase III clinical trials. As an alternative strategy, recent efforts have been focussed on the development of more selective inhibitors or ta...

Alternative Titles

Full title

The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_330c2dff71754c44b2d110c583e6ecdb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_330c2dff71754c44b2d110c583e6ecdb

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph14010031

How to access this item